The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Open accessAbstract
BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. METHODS: Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. RESULTS: Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. CONCLUSION: Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Breast cancer has become the most commonly diagnosed cancer worldwide, surpassing lung cancer [1, 2].”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of primary prevention, a reduction in excess body weight and alcohol consumption and increasing physical activity and breastfeeding may have an impact in reducing breast cancer incidence.58”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,222
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Secretan, B., Scoccianti, C., LOOMIS, D. P., Benbrahim‐Tallaa, L., Bouvard, V., Bianchini, F., & Straíf, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 966
Cited by
Sorted by citations
Items 501–600 of 1,000
Mengji, R., Paladugu, D., Saha, B., & Jana, A. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00432 · Cited by 12
Barriers to Breast Cancer Screening in Saudi Arabia: A Systematic Review and Meta-Analysis
Alsalamh, R., Al-Harbi, F. A., Alotaibi, R., Al-Harbi, O. N., Alshahrani, N., Alfadhel, S. M., Fatani, E. R., Alharbi, A., Lasloom, R. A. A., & Alzahrani, R. M. A. (2024) · Cureus · doi:10.7759/cureus.65103 · Cited by 12
Kingsberg, S. A., Banks, V., Caetano, C., Janssenswillen, C., Möeller, C., Schoof, N., Harvey, M., Scott, M., & Nappi, R. E. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108071 · Cited by 12
MSFN: a multi-omics stacked fusion network for breast cancer survival prediction
Zhang, G., Ma, C., Yan, C., Luo, H., Wang, J., Liang, W., & Luo, J. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1378809 · Cited by 12
Ibrahim, J.-N., El-Hakim, S., Semaan, J., Ghosn, S., Ayoubi, H. E., Elnar, A. A., Tohme, N., & Boustany, C. E. (2024) · Biomedicines · doi:10.3390/biomedicines12081779 · Cited by 12
Wong, H. C. Y., Lee, S. F., Caini, S., Chan, A. W., Kwan, J. Y. Y., Waddle, M. R., Sonis, S. T., Herst, P. M., Alcorn, S. R., Bonomo, P., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07435-2 · Cited by 12
Tang, Z., Wei, Y., Liang, Y., Zhu, X., Tang, J., Sun, Y., & Zhuang, Q. (2024) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000909 · Cited by 12
Choudhury, A., Chatterjee, S., Dalui, S., Ghosh, P., Daptary, A. H., Mollah, G. K., & Bhattacharyya, A. (2024) · Cell Biology International · doi:10.1002/cbin.12241 · Cited by 12
Kumar, S., & Chaudhri, S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155620 · Cited by 12
Vural, Ö., Buğday, N., Genç, A. A., Erk, N., Duygulu, Ö., & Yaşar, S. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c02551 · Cited by 12
Santos, V. E. P., Franca-Neto, P. L., Isídio, B. E. D. O., Fontes, P. H. B., de Moura, I. A., Cruz, B. I. S., de Sousa, M. M. G., dos Santos, D. L., Marcos, B. D. F. S., de Pinho, S. S., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120030 · Cited by 18
The oral-gut microbiome axis in breast cancer: from basic research to therapeutic applications
Huang, L., Jiang, C., Yan, M., Wan, W., Li, S., Xiang, Z., & Wu, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1413266 · Cited by 13
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications
Beňačka, R., Szabóová, D., Guľašová, Z., & Hertelyová, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010127 · Cited by 13
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Sebastião, A. I., Simões, G., Oliveira, F., Mateus, D., Falcão, A. C., Carrascal, M. A., Gomes, C. M. F., Neves, B. M., & Cruz, M. T. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102884 · Cited by 14
Therapeutic strategies and landscape of metaplastic breast cancer
Dai, P., Song, T., Liu, J., He, Z., Wang, X., Hu, R., & Yang, J. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102885 · Cited by 12
Gadakh, S., Aghav, B. D., Teraiya, N., Prajapati, D. G., Kamdar, J. H., Patel, B., & Yadav, R. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118142 · Cited by 12
The value of predicting breast cancer with a DBT 2.5D deep learning model
Niu, H., Li, L., Wang, X., & Han, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02170-6 · Cited by 12
Li, X., Zhang, Y. P., Gong, J., Liu, W., Zhao, H., Xue, W., Ren, Z., Bao, J., & Lin, Z. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02422-y · Cited by 11
Sarcopenia in patients with metastatic breast cancer: A systematic review and meta-analysis
Jang, M. K., Park, S., Park, C. G., Raszewski, R., Park, S., & Kim, S. (2025) · The Breast · doi:10.1016/j.breast.2025.104508 · Cited by 12
Pandey, S. N., Babu, M. A., Ali, H., Malathi, H., Maharana, L., Goyal, K., Rana, M., & Imran, M. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120387 · Cited by 12
Verma, N., Tamang, R., Mehata, A. K., Setia, A., Koch, B., & Muthu, M. S. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125907 · Cited by 12
Scully, O. J., Shyamasundar, S., Matsumoto, K., Dheen, S. T., Yip, G. W., & Bay, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021343 · Cited by 12
Fu, C., Wu, Z., Chang, W., & Lin, M. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-023-10394-7 · Cited by 12
Manda, R. R., Ratnakaram, V. N., Viveka, T. L., Angajala, G., & Aruna, V. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.135453 · Cited by 12
Advanced Fuzzy Sets and Genetic Algorithm Optimizer for Mammographic Image Enhancement
Dounis, A. I., Avramopoulos, A.-N., & Kallergi, M. (2023) · Electronics · doi:10.3390/electronics12153269 · Cited by 12
Exploring FGFR signaling inhibition as a promising approach in breast cancer treatment
Peng, Y., Zhang, P., Mei, W., & Zeng, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131524 · Cited by 12
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
Gul, S., Pang, J., Yuan, H., Chen, Y., yu, Q., Wang, H., & Tang, W. (2023) · Scientific Data · doi:10.1038/s41597-023-02709-8 · Cited by 12
Liu, J., Xiao, S., Huang, C., Zhang, X., Cai, R., Qu, S., Peng, Y., & Xie, L. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214380 · Cited by 11
Bandgar, M. D., Peddapelli, S., Kapavarapu, R., Boruwa, J., Kavela, S., & Narsimha, S. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00103j · Cited by 11
Silvaraju, G., Johari, N. A. S., Asmawi, A. A., Razali, R., Adam, F., Shan, Y. L., & Kamal, N. A. M. A. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06412-0 · Cited by 11
Lifestyle and Breast Cancer: Prevention and Treatment Support
Ratajczak, A. E., Jezierska, K., Szymczak‐Tomczak, A., Zawada, A. E., Rychter, A. M., Skoracka, K., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2025) · Cancers · doi:10.3390/cancers17172830 · Cited by 12
Shoari, A., Coban, M., & Radisky, E. S. (2025) · FEBS Journal · doi:10.1111/febs.70343 · Cited by 13
Sheikhnezhad, L., Hassankhani, H., Sawin, E. M., Sanaat, Z., & Sahebihagh, M. H. (2023) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2023.100193 · Cited by 11
Liu, J., Xu, X., Li, Y., Xu, J., Zhao, R., Liu, S., Wu, J., Zhang, L., & Zhang, B. (2023) · Biomaterials Science · doi:10.1039/d3bm00254c · Cited by 12
Arya, G. C., Khalid, M., Mehla, S., & Jakhmola, V. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2220819 · Cited by 11
Shoeibi, A., Karimi, E., Zareian, M., & Oskoueian, E. (2023) · Genes · doi:10.3390/genes14081547 · Cited by 11
Thepmalee, C., Sawasdee, N., Jenkham, P., Thephinlap, C., Khoothiam, K., Suwannasom, N., Chokchaisiri, R., Panya, A., & Yenchitsomanus, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115286 · Cited by 11
Czenczek‐Lewandowska, E., Szeliga, E., & Leszczak, J. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07088-7 · Cited by 11
Leme, J. C., Spinosa, R. M. D. O., Leal, S. O., Hirsch, A. B. B., Lodovico, A., Stramandinoli‐Zanicotti, R. T., Kunkel, M. E., & Moura, F. A. (2023) · Clinical Biomechanics · doi:10.1016/j.clinbiomech.2023.106123 · Cited by 11
Baban, M. M., Ahmad, S. A., Abu-Odeh, A., Baban, M., & Talib, W. H. (2023) · Plants · doi:10.3390/plants13010042 · Cited by 12
Breamy: An augmented reality mHealth prototype for surgical decision‐making in breast cancer
Najafi, N. N., Bassel, M. A., Meterissian, S. H., & Kersten‐Oertel, M. (2023) · Healthcare Technology Letters · doi:10.1049/htl2.12071 · Cited by 11
Aptamer-Based Recognition of Breast Tumor Cells: A New Era for Breast Cancer Diagnosis
de Araújo, N. S., Moreira, A. D. S., Abreu, R. D. S., Junior, V. V., Antunes, D., Mendonça, J. B., Sassaro, T. F., Jurberg, A. D., Ferreira‐Reis, R., Bastos, N. C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020840 · Cited by 11
Giannoula, A., Comas, M., Castells, X., Estupiñán‐Romero, F., Bernal‐Delgado, E., Sanz, F., & Sala, M. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad251 · Cited by 11
Patel, N. K., Kulshrestha, R., Bhat, A. A., Mishra, R., Singla, N., Gilhotra, R. M., & Gupta, G. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100378 · Cited by 12
Jaganathan, M., Ang, B. H., Ali, A., Sharif, S. Z., Mohamad, M., Khairy, A. M., Muniandy, K., Zainal, H., Sabtu, F., Sapiee, N., et al. (2024) · JCO Global Oncology · doi:10.1200/go.23.00297 · Cited by 11
Zhang, M., Zhang, L., Zhi, X., Fang, C., Yao, Y., Deng, R., Liu, C., & Wang, Y. (2024) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2024.03.015 · Cited by 11
Centrosomes and associated proteins in pathogenesis and treatment of breast cancer
Athwal, H., Kochiyanil, A., Bhat, V., Allan, A. L., & Parsyan, A. E. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1370565 · Cited by 10
Rossi, M., & Radisky, D. C. (2024) · Cancers · doi:10.3390/cancers16091615 · Cited by 11
Zhang, L., Sun, Q., Luan, H., Yuan, Q., Deng, T., Luo, L., & Tan, X. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15316 · Cited by 11
Alagarsamy, V., Sundar, P. S., Solomon, V. R., Murugesan, S., Muzaffar-Ur-Rehman, M., Kulkarni, V. S., Sulthana, M. T., Narendhar, B., & Sabarees, G. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128287431240408045732 · Cited by 11
Terefinko, D., Dzimitrowicz, A., Bielawska‐Pohl, A., Pohl, P., Klimczak, A., & Jamróz, P. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105846 · Cited by 11
Glyoxalase System in Breast and Ovarian Cancers: Role of MEK/ERK/SMAD1 Pathway
Alhujaily, M. M. (2024) · Biomolecules · doi:10.3390/biom14050584 · Cited by 12
Lambert-Obry, V., Kane, S., Howidi, B., Ngoc, N. B., Chandiwana, D., Wu, Y., Edwards, M., & Samjoo, I. A. (2024) · BMC Cancer · doi:10.1186/s12885-024-12269-8 · Cited by 11
Olayiwola, Y., & Gollahon, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126417 · Cited by 11
Boutahar, K., Laghmati, S., Moujahid, H., Gannour, O. E., Cherradi, B., & Raihani, A. (2024) · International Conference on Innovative Research in Applied Science, Engineering and Technology (IRASET) · doi:10.1109/iraset60544.2024.10549284 · Cited by 11
Development and validation of a clinical breast cancer tool for accurate prediction of recurrence
Dhungana, A., Vannier, A., Zhao, F., Freeman, J. Q., Saha, P., Sullivan, M. E., Yao, K. A., Flores, E. M., Olopade, O. I., Pearson, A. T., et al. (2024) · npj Breast Cancer · doi:10.1038/s41523-024-00651-5 · Cited by 12
Ferroptosis and circular RNAs: new horizons in cancer therapy
Bhat, A. A., Kukreti, N., Afzal, M., Goyal, A., Thapa, R., Ali, H., Shahwan, M. J., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., et al. (2024) · EXCLI journal · doi:10.17179/excli2024-7005 · Cited by 12
Paizula, X., Wulaying, A., Chen, D., & Ou, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-64687-0 · Cited by 11
Masarkar, N., Pal, M., Roy, M., Yadav, A. K., Pandya, B., Lokhande, S. L., Kanwar, J. R., Ray, S. K., & Mukherjee, S. (2024) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2024-0176 · Cited by 11
Ahmadi, H., Heydari, M., Abdouss, M., Jamalpoor, Z., Fathi‐karkan, S., Rahdar, A., & Pandey, S. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100202 · Cited by 12
Hao, S., Jia, Y. D., Liu, J., Wang, Z., Liu, C., Ji, Z., & Ганчев, И. (2024) · IEEE Access · doi:10.1109/access.2024.3445954 · Cited by 11
A Vision Transformer Approach for Breast Cancer Classification in Histopathology
Sabry, M., Balaha, H. M., Ali, K. M., Soliman, T. H. A., Gondim, D. D., Ghazal, M. A., Tahtouh, T., & El-Baz, A. S. (2024) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi56570.2024.10635515 · Cited by 11
Raj, A. S. W. W., & Manoharan, R. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167508 · Cited by 11
Ukani, H., Singh, P., Banerjee, M., Parsana, N., Mehra, S., Kumar, A., Kadam, Y., & Malek, N. I. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126022 · Cited by 11
Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer
Chen, X., Liu, Y., Zhu, W., Li, S., Wei, S., Cai, J., Lin, Y., Liang, J., Yan, G., Guo, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111148 · Cited by 11
Menchinskaya, E. S., Chingizova, E. A., Pislyagin, Е. А., Yurchenko, E. A., Климович, А. А., Zelepuga, E., Aminin, D. L., Avilov, S. A., & Silchenko, A. S. (2024) · Marine Drugs · doi:10.3390/md22100474 · Cited by 11
Plant‐Based Anticancer Compounds With a Focus on Breast Cancer
Hasan‐Abad, A. M., Atapour, A., Nasab, A. S., Motedayyen, H., & Arefnezhad, R. (2024) · Cancer Reports · doi:10.1002/cnr2.70012 · Cited by 11
Fouad, F. A., Khali, M. A., Moaz, I. M., Elmasry, H., Gheta, N., Abdeen, A., Tantawi, M., Elkholy, G., Rihan, S., Kamel, M. M., et al. (2024) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320241304911 · Cited by 11
Elliott, K., Haworth, E. J., Bolnykh, I., McAllister-Williams, H., Greystoke, A., Todd, A., & Sharp, L. (2024) · The Breast · doi:10.1016/j.breast.2024.103855 · Cited by 12
Liu, W., Zhang, J., Zhang, J., Ye, Y., Zhu, J., Yu, Q., Li, T., Sun, X., & Chen, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1476731 · Cited by 11
CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting
Ghosh, P., Dey, A., Nandi, S., Majumder, R., Das, S., & Mandal, M. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10248-4 · Cited by 11
Hedemann, N., Thomas, A., Tribian, N., Amler, A.-K., Krüger, S., Holthaus, D., Huebbe, P., Flörkemeier, I., Weimer, J. P., Maass, N., et al. (2025) · Biofabrication · doi:10.1088/1758-5090/adb890 · Cited by 12
Chen, Y., Xue, D., Huang, D., Li, X., Duan, Y., & Chen, B. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01636 · Cited by 11
Ghadimi, P., & Ghorbian, . (2025) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70010 · Cited by 11
Tripathi, K. L., Dwivedi, V. D., & Badoni, H. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11165-y · Cited by 11
Lamiraud, F. M., Bensmail, H., Martin, C., Pelckmans, S., Cha'ban, F., Frisch, A. S., Deniz, G., Serfati, P. S., Caubo, B., Gurriet, B., et al. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108264 · Cited by 11
Advancing breast cancer therapy in the era of molecular diagnostics
Carnevale, M. G., Colciago, R. R., Santis, M. C. D., Cortesi, L., Marco, C. D., Marra, A., Vingiani, A., Nolè, F., Curigliano, G., Pruneri, G., et al. (2025) · The Breast · doi:10.1016/j.breast.2025.104488 · Cited by 12
Wang, W., Sun, Y., Li, J., Bai, H., Ren, C., Feng, Y., & Wang, S. (2025) · BMC Cancer · doi:10.1186/s12885-025-14416-1 · Cited by 11
Terpstra, K., GUTIERREZ, C. G., Gui, K., & Mirica, L. M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00493 · Cited by 11
Mendes, J., Matela, N., & Garcia, N. C. (2023) · Tomography · doi:10.3390/tomography9010032 · Cited by 11
Majidi, H. J., Zabihi, E., Arab‐Bafrani, Z., Mir, S. M., & Reiter, R. J. (2023) · 2D Materials · doi:10.1088/2053-1583/acc413 · Cited by 11
Tonyan, S. N., Pospelova, M. L., Krasnikova, V. V., Fionik, O. V., Alekseeva, T. M., Samochernykh, K. A., Ivanova, N., Вавилова, Т. В., Vasilieva, E. Y., Makhanova, A. M., et al. (2023) · Pathophysiology · doi:10.3390/pathophysiology30020010 · Cited by 11
Pekarek, L., Cendra, A. S., Cervantes, E. D. R., Cendra, C. S., Fraile‐Μartinez, O., Montero, C. G., Dı́az, R., Torres‐Carranza, D., López-González, L., Aguado-Henche, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098396 · Cited by 11
Mangiardi-Veltin, M., Mullaert, J., Cœuret-Pellicer, M., Goldberg, M., Zins, M., Rouzier, R., Héquet, D., & Bonneau, C. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01407-z · Cited by 13
Singh, A., Singh, K., Sharma, A., Sharma, S., Batra, K., Joshi, K., Singh, B., Kaur, K., Chadha, R., & Bedi, P. M. S. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04786-0 · Cited by 11
Prediction of breast cancer based on computer vision and artificial intelligence techniques
Khan, A. I., Abushark, Y. B., Alsolami, F. J., Almalawi, A., Alam, M. M., Kshirsagar, P. R., & Khan, R. A. (2023) · Measurement · doi:10.1016/j.measurement.2023.113230 · Cited by 11
Tosun, N. G. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02807-9 · Cited by 11
Li, X., Zhang, Y., An, Q., Su, S., Wang, Y., Bai, L., Zeng, J., Xu, X., Wong, W., Wang, Y., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202508811 · Cited by 11
Prasanna, R., & Karumuri, S. R. (2025) · Microsystem Technologies · doi:10.1007/s00542-025-05938-6 · Cited by 12
Garg, P., Krishna, M., Horne, D. A., Salgia, R., & Singhal, S. S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189490 · Cited by 11
The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer
Zhang, H. F., Wang, Y., Ning, B., Wang, Y., Sun, T., & Xu, J. (2026) · Annals of Medicine · doi:10.1080/07853890.2025.2611203 · Cited by 11
Tiwari, P., Nadeem, M., Dua, S., Rizvi, M. M., & Arfin, N. (2023) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2023.100164 · Cited by 10
Application of Biosensors in Detecting Breast Cancer Metastasis
Deng, Y., Zhang, Y., Zhou, M., Wu, B., & Zhou, J. (2023) · Sensors · doi:10.3390/s23218813 · Cited by 10
FAAH inhibition ameliorates breast cancer in a murine model
Tripathy, M., Bui, A., Henderson, J. M., Sun, J. C., Woods, C. R., Somani, S., Doan, T., Titus, A. S. C. L. S., & Mohan, C. (2023) · Oncotarget · doi:10.18632/oncotarget.28534 · Cited by 10
Kubeczko, M., Tudrej, P., Tyszkiewicz, T., Krzywon, A., Oczko‐Wojciechowska, M., & Jarząb, M. (2024) · Oncology Letters · doi:10.3892/ol.2024.14314 · Cited by 10
Feng, K., Di, Y., Han, M., Yan, W., & Wang, Y. (2024) · Aging · doi:10.18632/aging.205632 · Cited by 10
Khazaei, M. R., Bozorgi, M., Khazaei, M., Moradi, A., & Bozorgi, A. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09328-5 · Cited by 10
Encapsulation and release of calcein from herceptin-conjugated eLiposomes
Zafar, M. N., Pitt, W. G., & Husseini, G. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27882 · Cited by 10
Protease-activated receptor 2: A promising therapeutic target for women’s cancers
Shah, H., Fairlie, D. P., & Lim, J. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002176 · Cited by 10
Rentroia‐Pacheco, B., Bellomo, D., Lakeman, I. M. M., Wakkee, M., Hollestein, L. M., & Klaveren, D. V. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02213-6 · Cited by 10
Metadata
- Authors
- Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., & Soerjomataram, I.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- American Society of Clinical Oncology (US)
- Netherlands Comprehensive Cancer Organisation (NL)
- Corresponding author
- Morgan, Eileen
- ORCID
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 66
- Pages
- 15-23
- ISSN
- 0960-9776 (ISSN-L)
- PMC
- PMC9465273
- OpenAlex
- W4294189863
- Cited by
- 3,411
- References
- 43
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 997 · 2023: 516 · 2022: 23
- FWCI
- 284.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Breast (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Funders
- Susan G. Komen (CCR19608129)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, global burden of disease, incidence, mortality, age-standardized rates, population projections, 2040 projections, regional variation, human development, cancer epidemiology
- MeSH terms
- Australia, Breast Neoplasms, Europe, Female, Forecasting, Humans, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review